Epilepsy Today Latest News
Epilepsy medicines pregabalin and gabapentin to be reclassified as class C drugs to help minimise possible misuse
The UK government announced last week that the medicines pregabalin and gabapentin will be reclassified as class C under the Misuse of Drugs Act 1971. The change will take place in April 2019.
The Neurological Alliance is carrying out its third patient experience survey. The alliance is asking people with neurological conditions, such as epilepsy, to share their experiences of neurology services.
Accord topiramate tablets are out of stock in all doses. Accord does not know when they will be back in stock.
Other manufacturer’s versions of topiramate are available. If you have any concerns about taking a different version, speak to your doctor, epilepsy nurse or pharmacist.
Actavis topiramate 100mg tablets are temporarily out of stock. Actavis expects to have them back in stock on 24 October 2018.
All other doses of Actavis topiramate are available.
The Home Secretary Sajid Javid today formally announced the rescheduling of cannabis-based medicinal products. The changes will come into effect on 1 November.
Epilepsy Action senior policy and campaigns officer Sam Mountney provides an update on the current situation with cannabis-based medicines in the UK
There’s been a shortage of Tegretol (carbamazepine) liquid, but it’s now back in stock. The company that makes Tegretol liquid, Novartis, says it should be available from pharmacists by 12 October 2018.
Update on 8 October 2018: Sanofi have been in touch to say Epilim Chronosphere 500mg are now back in stock.
Update on 5 October 2018: Sanofi now expects to have these back in stock in the week commencing 22 October.